World-first benchmarks set for primary hyperparathyroidism care
Research has shown many patients are undertreated or fail to receive optimal care, clinicians say
An expert panel of clinicians has developed a world-first set of quality indicators for primary hyperparathyroidism care in a bid to optimise management and cost-effectiveness.
Using a consensus-based approach, the Canadian researchers have proposed 18 individual indicators for the diagnosis and treatment of primary hyperparathyroidism (pHPT).
